Functional Neurological Disorder (FND) involves neurological symptoms arising from brain network changes rather than structural damage, often described as a “software” issue rather than a “hardware” problem. Symptoms…
Pompe disease is a progressive, life-threatening genetic neuromuscular disorder. Late-onset Pompe disease (LOPD), affecting individuals over one year old, leads to trunk and proximal muscle weakness, often impacting…
NEW YORK (Reuters Health) – Diffusion-weighted imaging (DWI) with a newer 3.0 Tesla magnetic resonance image (MRI) scanner may be less accurate than with an older 1.5 T…
NEW YORK (Reuters Health) – Cerebral microbleeds increase the risk of intracerebral hemorrhage (ICH) in patients taking warfarin, a new study suggests. “These results have potentially worrying implications…
NEW YORK (Reuters Health) – Endovascular therapy for acute ischemic stroke is at least as safe in nonintubated versus intubated patients, a small, retrospective study shows. As reported…
NEW YORK (Reuters Health) – Patients with macroprolactinemia don’t need extensive exams or prolonged monitoring, according to a prospective study. As long as their monomeric prolactin concentration is…
NEW YORK (Reuters Health) – The dopamine agonist pramipexole relieves depressive symptoms in patients with Parkinson’s disease, according to a study published online May 10th in The Lancet…
NEW YORK (Reuters Health) – Dizziness in the elderly is caused by cardiovascular disease in over half of patients seen in primary care, according to new research from…
NEW YORK (Reuters Health) – Patients with vascular dementia who took the acetylcholinesterase inhibitor donepezil had mild improvements in cognitive function, but not global function, in an international…
NEW YORK (Reuters Health) – The TNF alpha inhibitor adalimumab provides minor analgesia in patients with radicular pain due to lumbar disc herniation, but prompts a major reduction…
NEW YORK (Reuters Health) – Using recombinant tissue plasminogen activator (rtPA) within existing licensing limits is fully justified by available data – but there’s not enough data to…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate (MgSO4) does not benefit patients with acute aneurysmal subarachnoid hemorrhage, according to results of a phase III trial. In the…
